SG Americas Securities’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

SG Americas Securities’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7,145	Closed	-$260K	–	3740
2016 Q4	$260K	Buy	+7,145	New	+$253K	﹤0.01%	2159
2016 Q3	–	Sell	-56,769	Closed	-$464K	–	3591
2016 Q2	$464K	Hold	56,769	–	–	﹤0.01%	1737
2016 Q1	$352K	Buy	56,769 +4,504	+9%	+$28.1K	﹤0.01%	1922
2015 Q4	$437K	Buy	+52,265	New	+$275K	﹤0.01%	1692

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

SG Americas Securities's CLCD Position: Q1 2017 in Review

SG Americas Securities sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 7,145 shares — an estimated $260K sold.

SG Americas Securities first reported a position in CLCD in Q4 2015 and held it in 4 quarters. The position peaked at $464K in Q2 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

SG Americas Securities reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
SG Americas Securities sold 7,145 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $260K.
SG Americas Securities first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2015 and held it in 4 quarters.
SG Americas Securities's CoLucid Pharmaceuticals, Inc. position peaked at $464K in Q2 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on SG Americas Securities's 13F filing for Q1 2017, filed 10 May 2017.